Clinical Implications of Elevated Asymmetric Dimethylarginine in Chronic Kidney Disease and End-Stage Renal Disease

Journal of Renal Nutrition

Volumn 19, Issue 1, 2009, Pages 25-28

  Mallamaci, Francesca ^a   Zoccali, Carmine ^a  

^a CNR Consiglio Nazionale delle Ricerche   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; DRUG DERIVATIVE; N,N DIMETHYLARGININE; N,N-DIMETHYLARGININE;

ARTICLE; BLOOD; CARDIOVASCULAR DISEASE; CAROTID ARTERY; CHRONIC KIDNEY FAILURE; HUMAN; KIDNEY DISEASE; MORTALITY; PATHOLOGY; PATHOPHYSIOLOGY; RISK FACTOR; UREMIA;

ARGININE; CARDIOVASCULAR DISEASES; CAROTID ARTERIES; HUMANS; KIDNEY DISEASES; KIDNEY FAILURE, CHRONIC; RISK FACTORS; UREMIA;

ANIMALIA;

EID: 58149085227     PISSN: 10512276     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.jrn.2008.10.013     Document Type: Article

References (18)

1. Richet G. Edema and uremia from 1827 to 1905: the first faltering steps of renal pathophysiology. Kidney Int 43 (1993) 1385-1396
2. Giovannetti S., Biagini M., Balestri P.L., et al. Uraemia-like syndrome in dogs chronically intoxicated with methylguanidine and creatinine. Clin Sci 36 (1969) 445-452
3. Vanholder R., De Smet S.R., Glorieux G., et al. Review on uremic toxins: classification, concentration, and interindividual variability. Kidney Int 63 (2003) 1934-1943
4. Doll R. Sir Austin Bradford Hill and the progress of medical science. BMJ 305 (1992) 1521-1526
5. Kielstein J.T., and Zoccali C. Asymmetric dimethylarginine: a cardiovascular risk factor and a uremic toxin coming of age?. Am J Kidney Dis 46 (2005) 186-202
6. Ravani P., Tripepi G., Malberti F., et al. Asymmetrical dimethylarginine predicts progression to dialysis and death in patients with chronic kidney disease: a competing risks modeling approach. J Am Soc Nephrol 16 (2005) 2449-2455
7. Zoccali C., Bode-Boger S., Mallamaci F., et al. Plasma concentration of asymmetrical dimethylarginine and mortality in patients with end-stage renal disease: a prospective study. Lancet 358 (2001) 2113-2117
8. Suda O., Tsutsui M., Morishita T., et al. Asymmetric dimethylarginine produces vascular lesions in endothelial nitric oxide synthase-deficient mice: involvement of renin-angiotensin system and oxidative stress. Arterioscler Thromb Vasc Biol 24 (2004) 1682-1688
9. Leiper J., Nandi M., Torondel B., et al. Disruption of methylarginine metabolism impairs vascular homeostasis. Nat Med 13 (2007) 198-203
10. Achan V., Broadhead M., Malaki M., et al. Asymmetric dimethylarginine causes hypertension and cardiac dysfunction in humans and is actively metabolized by dimethylarginine dimethylaminohydrolase. Arterioscler Thromb Vasc Biol 23 (2003) 1455-1459
11. Kielstein J.T., Simmel S., Bode-Boger S.M., et al. Subpressor dose asymmetric dimethylarginine modulates renal function in humans through nitric oxide synthase inhibition. Kidney Blood Press Res 27 (2004) 143-147
12. Zoccali C., Benedetto F.A., Maas R., et al. Asymmetric dimethylarginine, C-reactive protein, and carotid intima-media thickness in end-stage renal disease. J Am Soc Nephrol 13 (2002) 490-496
13. Meinitzer A., Seelhorst U., Wellnitz B., et al. Asymmetrical dimethylarginine independently predicts total and cardiovascular mortality in individuals with angiographic coronary artery disease (the Ludwigshafen Risk and Cardiovascular Health study). Clin Chem 53 (2007) 273-283
14. Scalera F., Borlak J., Beckmann B., et al. Endogenous nitric oxide synthesis inhibitor asymmetric dimethyl L-arginine accelerates endothelial cell senescence. Arterioscler Thromb Vasc Biol 24 (2004) 1816-1822
15. Thum T., Tsikas D., Stein S., et al. Suppression of endothelial progenitor cells in human coronary artery disease by the endogenous nitric oxide synthase inhibitor asymmetric dimethylarginine. J Am Coll Cardiol 46 (2005) 1693-1701
16. Jimenez R., Carracedo J., Santamaria R., et al. Replicative senescence in patients with chronic kidney failure. Kidney Int Suppl (2005) S11-S15
17. Smith C.L., Anthony S., Hubank M., et al. Effects of ADMA upon gene expression: an insight into the pathophysiological significance of raised plasma ADMA. PLoS Med 2 (2005) e264
18. Iribarren C., Husson G., Sydow K., et al. Asymmetric dimethyl-arginine and coronary artery calcification in young adults entering middle age: the CARDIA Study. Eur J Cardiovasc Prev Rehabil 14 (2007) 222-229